HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Use of methylphenidate in palliative patients with asthenia: a review].

Abstract
Asthenia (or fatigue) is one of the most common symptoms in palliative patients. Methylphenidate is currently being assessed for treating this condition. A review of related literature published to date was performed, revealing methylphenidate to be a safe drug which could decrease fatigue in palliative patients with a tolerable side-effects profile.
AuthorsA Saralegui, P Palacio, P Royo
JournalAnales del sistema sanitario de Navarra (An Sist Sanit Navar) Vol. 36 Issue 2 Pg. 287-93 (Sep 06 2013) ISSN: 2340-3527 [Electronic] Spain
Vernacular TitleRevisión sobre el uso del metilfenidato para el tratamiento de la astenia en pacientes paliativos.
PMID24008532 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Dopamine Uptake Inhibitors
  • Methylphenidate
Topics
  • Asthenia (drug therapy)
  • Dopamine Uptake Inhibitors (therapeutic use)
  • Fatigue (drug therapy)
  • Humans
  • Methylphenidate (therapeutic use)
  • Palliative Care

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: